In the pharmaceutical sector, robotics is propelling innovation, showcased through significant advancements. Strategic deals and investments are transforming the industry, marked by a notable increase, while workforce dynamics reveal a distinctive shift in hiring trends, indicating the evolving role of robotics in the field. The impact of robotics extends beyond the pharmaceutical sector, influencing various industries. GlobalData’s robotics market report provides a detailed understanding on how robotics impacts the value chain in the healthcare sector, and the leading robotics adopters and vendors in the market. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Robotics in Healthcare - Thematic Intelligence

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

This article presents a quarterly round-up of the latest trends in the pharmaceutical industry regarding robotics. It provides an overview of recent developments in robotics-related deals, talent acquisition, and patent filings within the pharmaceutical industry.

Diverse applications of robotics in pharmaceutical industry

Pharmaceutical companies are leveraging robotics technologies to innovate and improve their businesses, as evidenced by the latest patents in the field. One such patent from the University of Macau describes a cell microinjection system with force feedback. This system overcomes the limitations of conventional position control by integrating strain-gage sensors to detect cell penetration force and micropipette position in real time. The system demonstrates high operation speed, a confident success rate, and a high survival rate for injected embryos. Another patent from Becton Dickinson and Co introduces a picktool manipulator device that collects specimens from a culture medium. The device operates in different modes to determine the height at which the picktool contacts the medium. These patents highlight the advancements in robotics technologies for pharmaceutical applications, offering improved precision and efficiency in cell manipulation and specimen collection. The acquirer of these patents stands to benefit from enhanced capabilities in their robotics-based processes, leading to improved research and development outcomes in the pharmaceutical industry.

The industry experienced a 62% decline in the number of robotics-related patent applications in Q3 2023 compared with the previous quarter. On an annual basis, the number of robotics-related patent applications in the pharmaceutical industry witnessed a drop of 48% compared with Q3 2022.

Strategic deal trends in robotics in pharmaceutical industry

Pharmaceutical companies are not only focusing on innovation to enhance their patent portfolios but are also making strategic investments in robotics. These investments aim to secure lucrative deals with partners and position themselves at the forefront of industry advancements. Some of the recent deals underscore the importance of robotics in the pharmaceutical industry.

In Q3 2023, the number of robotics-related deals in the pharmaceutical industry declined by 18% compared with Q3 2022. On a quarterly basis, there was 80% increase in the number of deals in Q3 2023 compared with the previous quarter.

Impact on hiring

In terms of new job posting, in Q3 2023, the pharmaceutical industry experienced a 36% drop compared with the previous quarter. On an annual basis, job postings also declined by 46%. Notably, life, physical, and social science occupations, with a share of 17%, emerged as the top robotics-related job roles within the pharmaceutical industry in Q3 2023, with new job postings drop by 22% quarter-on-quarter. Architecture and engineering occupations came in second with a share of 13% in Q3 2023, with new job postings rising by 13% over the previous quarter. The other prominent robotics roles include management occupations with a 10% share in Q3 2023, and computer and mathematical occupations with a 10% share of new job postings.

Novo Nordisk, Johnson & Johnson, Aurora Cannabis, Charles River Laboratories International, and Bayer are among the top companies leading in robotics hiring within the pharmaceutical industry.

Countries driving adoption of robotics in pharmaceutical industry

The US is the leading country in robotics adoption within the pharmaceutical industry, boasting the highest number of robotics-related patents, jobs, and deals. Meanwhile, South Korea, China, the UK and Italy also maintain significant positions in robotics adoption within the pharmaceutical industry.

In conclusion, the symbiotic relationship between robotics and the pharmaceutical industry is evident in the strides of innovation showcased through patents, strategic deals, and workforce dynamics. As companies navigate this transformative landscape, the integration of robotics is poised to drive enhanced precision, efficiency, and strategic advancements, shaping the future of pharmaceutical research and development globally.

To further understand GlobalData's analysis on robotics in the pharmaceutical industry, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData patent analytics tracks patent filings and grants across companies and themes. Proprietary databases on deals and job analytics are used to respectively monitor global deal activity and uncover insights from daily job postings to identify trends, company activities, and industry dynamics across different sectors globally.